Member Info for DD77

A couple of big transactions going through, one for 2% of the company. Looks like we're now starting to see an upturn in SP

MCAP now £13m. The potential here is ridiculous and MCAP should already be multiples of this level. I’m not concerned for the long term, in fact it provides a wonderful opportunity to buy in or top up now

The award of options at 93.5p is hardly inspiring!

£11m MCAP. This is all

Most have one HQ but not all. Unilever had HQs in Netherlands and London until recently

Yes, Krusty the Clown

What’s kicked this into life today? Or is it just a rebound from the market sell off earlier in the week?

Why do you think it's going to be a stretch?

So they have previously announced that they believe they have enough cash to get to break-even stage

I should also mention, £7.8m in cash, and MCAP only £24m. Yes they've made plenty of mistakes in the past but they're now on the right track with a low cost of capital licencing model which should generate significant £

I agree, lots of positive snippets. They just need further commercial deals to be signed so as not to be soundbites!

Key snippets:

XFiltra
* Since September, the Company has commenced the negotiation of joint development agreements with three additional major players.
* Another commercial laundry OEM in early-stage discussions with the Company regarding XFiltra for a model that they plan to start selling in Q2 2023.

Denim:
Discussions have recently commenced to license Xeros' technology in Turkey which is another major production hub for denim. Xeros' plans are supported by the above results and the benefits case which continues to be validated both from an environmental and a financial perspective as well as the successful tests recently completed with three major denim brands.

"Over the last four months engagements with prospective partners increased significantly and our expectation is that we will see additional agreements signed during 2022, with some anticipated in the near term."

Undoubtedly a disappointing RNS. Cleaning and beauty revenues down on prior year, noone expected that. No real explanation for why other than inventory build - I would not expect it to account for all the difference, so where has the growth been in these sectors? Cash also a growing concern with a likely raise in 2022, as break even isn't forecasted till next year. There are snippets to cling onto, together with the recent research note but as a whole this is underwhelming and there are growing question marks here - that leads to PI uncertainty which will depress the SP for some time.

It would be good if John could do another Investor Presentation, although the last couple have been underwhelming and haven't revealed much. These will be bottom drawer now for a while I feel, they're not going to experience the upturn I expected in the short term

Huge milestone achieved

Correction, 18th March

So parliament ran out of time so didn't hear it.............you couldn't make it up. What a bunch of useless.................now been postponed until April I think

The company has lost a 3rd of its value in 2 months

Big decline in the SP recently..............any thoughts? I know the H1 results were somewhat underwhelming

Yet the SP continues to decline.........

Why are people so desperate for an RNS? Usually people sell on news.........

Pensioner 59 - thanks for sharing the link.

Nice to see an indication on when break even is likely to be, although I think we all thought 23 was most likely.

The report is quite conservative, but does indicate a scenario where we could have accelerated growth:

Management is ambitious and entrepreneurial, and it sees the current market environment as ideal
for pushing forward with its growth plans. We also see potential for the group to accelerate its
growth strategy, which would include scaling-up operations and marketing-support costs in the
short term to generate a more rapid conversion of customer project opportunities. It would
promote R&D investment in new formulations for longer-term commercial gain. This scenario would
involve additional overhead spending of around $1.6m over the next two years with additional
capex of around $3.0-$3.5m, but would accelerate revenue growth by around 20-25%. The accelerated scenario clearly could have a significant impact on revenues, with a potentially robust profit accretion within a couple of years